BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19332245)

  • 1. Surgical management of recurrent ovarian cancer.
    Leitao MM; Chi DS
    Semin Oncol; 2009 Apr; 36(2):106-11. PubMed ID: 19332245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer.
    Munkarah AR; Coleman RL
    Gynecol Oncol; 2004 Nov; 95(2):273-80. PubMed ID: 15491746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for recurrent ovarian cancer.
    Rose PG
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):17-23. PubMed ID: 10952122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.
    Pothuri B; Meyer L; Gerardi M; Barakat RR; Chi DS
    Gynecol Oncol; 2004 Oct; 95(1):193-5. PubMed ID: 15385131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Locoregional recurrence of ovarian cancer: the place of surgery].
    Classe JM; Catala L; Marchal F; Ferron G; Dravet F; Pioud R; Descamps P
    Bull Cancer; 2004 Nov; 91(11):827-32. PubMed ID: 15582885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-line treatment of first relapse recurrent ovarian cancer.
    Chua TC; Liauw W; Robertson G; Morris DL
    Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):465-71. PubMed ID: 21039382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.
    Pavlov MJ; Kovacevic PA; Ceranic MS; Stamenkovic AB; Ivanovic AM; Kecmanovic DM
    Eur J Surg Oncol; 2009 Nov; 35(11):1186-91. PubMed ID: 19356887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing for starting second-line therapy in recurrent ovarian cancer.
    Guarneri V; Barbieri E; Dieci MV; Piacentini F; Conte P
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):49-55. PubMed ID: 21166510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
    Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
    Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of secondary cytoreductive surgery for recurrent ovarian cancer.
    Güngör M; Ortaç F; Arvas M; Kösebay D; Sönmezer M; Köse K
    Gynecol Oncol; 2005 Apr; 97(1):74-9. PubMed ID: 15790440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current surgical management in ovarian cancer recurrences].
    Tinelli FG; Tinelli A; Campagnutta E; Kobal B; Rakar S; Manca C; Tinelli R; Perrone A
    Minerva Ginecol; 2004 Oct; 56(5):457-67. PubMed ID: 15531862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
    Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
    Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive surgery for recurrent ovarian cancer.
    Hauspy J; Covens A
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):15-21. PubMed ID: 17218846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of recurrent ovarian carcinoma: current status and future directions.
    Martin LP; Schilder RJ
    Semin Oncol; 2009 Apr; 36(2):112-25. PubMed ID: 19332246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer.
    Sugarbaker PH
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):15-24. PubMed ID: 19124999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does secondary surgical cytoreduction improve survival in women with advanced ovarian cancer?
    Munkarah A
    Nat Clin Pract Oncol; 2005 Apr; 2(4):188-9. PubMed ID: 16264930
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of surgery in ovarian carcinoma.
    Fader AN; Rose PG
    J Clin Oncol; 2007 Jul; 25(20):2873-83. PubMed ID: 17617518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critique of surgical cytoreduction in advanced ovarian cancer.
    Covens AL
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):269-74. PubMed ID: 10985879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.
    Bristow RE; Peiretti M; Gerardi M; Zanagnolo V; Ueda S; Diaz-Montes T; Giuntoli RL; Maggioni A
    Gynecol Oncol; 2009 Aug; 114(2):173-7. PubMed ID: 19482344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.